| Literature DB >> 35562923 |
Luciana Sartore1, Chiara Pasini1, Stefano Pandini1, Kamol Dey1,2, Marco Ferrari3,4, Stefano Taboni3,4, Harley H L Chan5, Jason Townson5, Sowmya Viswanathan6, Smitha Mathews6, Ralph W Gilbert7, Jonathan C Irish5,7, Federica Re8, Piero Nicolai3, Domenico Russo8.
Abstract
A great promise for tissue engineering is represented by scaffolds that host stem cells during proliferation and differentiation and simultaneously replace damaged tissue while maintaining the main vital functions. In this paper, a novel process was adopted to develop composite scaffolds with a core-shell structure for bone tissue regeneration, in which the core has the main function of temporary mechanical support, and the shell enhances biocompatibility and provides bioactive properties. An interconnected porous core was safely obtained, avoiding solvents or other chemical issues, by blending poly(lactic acid), poly(ε-caprolactone) and leachable superabsorbent polymer particles. After particle leaching in water, the core was grafted with a gelatin/chitosan hydrogel shell to create a cell-friendly bioactive environment within its pores. The physicochemical, morphological, and mechanical characterization of the hybrid structure and of its component materials was carried out by means of infrared spectroscopy, thermogravimetric analysis, scanning electron microscopy, and mechanical testing under different loading conditions. These hybrid polymer devices were found to closely mimic both the morphology and the stiffness of bones. In addition, in vitro studies showed that the core-shell scaffolds are efficiently seeded by human mesenchymal stromal cells, which remain viable, proliferate, and are capable of differentiating towards the osteogenic phenotype if adequately stimulated.Entities:
Keywords: bone tissue regeneration; composite scaffolds; human mesenchymal stromal cells; hybrid polymer device; hydrogels; open-pore PLA-PCL core; tissue engineering
Mesh:
Substances:
Year: 2022 PMID: 35562923 PMCID: PMC9101363 DOI: 10.3390/ijms23094533
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Scheme 1Main steps of the preparation of the core-shell scaffolds.
Figure 1FTIR spectra of the neat starting materials (PLA, PCL), of the hydrogel constituting the shell (Hy) and of the assembled core-shell system (PLA-PCL-Hy).
Figure 2TGA traces of the uncoated core (PLA-PCL), of the assembled core-shell system (PLA-PCL-Hy) and of the neat hydrogel (Hy).
Composition and absorbed water of PLA-PCL-SAP, PLA-PCL and PLA-PCL-Hy.
| Material | PLA [wt.%] | PCL [wt.%] | SAP [wt.%] | Hy [wt.%] | Absorbed Water [%] |
|---|---|---|---|---|---|
| PLA-PCL-SAP | 54.8 | 13.7 | 31.5 | - | 3500 |
| PLA-PCL | 80.0 | 20.0 | - | - | 152 |
| PLA-PCL-Hy | 77.6 | 19.4 | - | 3.0 | 150 |
Figure 3Morphological analysis of cryogenically obtained cross-sections for the PLA-PCL-SAP biocomposite material (A,D), for porous PLA-PCL (B,E) and for the core-shell assembly, PLA-PCL-Hy (C,F). Scale bars 300 µM (A–C) and 70 µM (D–F).
Figure 4Stress vs. strain curves for specimens of PLA-PCL and PLA-PCL-Hy measures in (A) tensile, (B) compression, and (C) bending tests.
Stiffness, strength and failure strain of PLA-PCL and PLA-PCL-Hy.
| Loading | PLA-PCL | PLA-PCL-Hy | ||||
|---|---|---|---|---|---|---|
| Modulus | Failure Stress | Failure Strain | Modulus | Failure Stress | Failure Strain | |
| Tensile | 110 ± 14 | 0.9 ± 0.2 | 2.4 ± 0.3 | 100 ± 30 | 1.5 ± 0.6 | 3.5 ± 0.7 |
| Compression | 50 ± 17 | 4.3 ± 1.5 | - | 70 ± 15 | 5.3 ± 0.8 | - |
| Bending | 210 ± 15 | 3.0 ± 0.3 | 2.8 ± 0.4 | 210 ± 40 | 5 ± 1 | 5.0 ± 0.2 |
Figure 5Panel showing epifluorescence microscopy of scaffolds made of poly(ethylene glycol) diglycidyl ether-chitosan (A,C,E) and the same material within a poly(L-lactic acid), poly(ε-caprolactone) blend (B,D,F). (A,B) The scaffolds were seeded with 1000 cell/mm3 hBM-MSCs and stained with calcein (green, live cells) and propidium iodide (red, dead cells) 4 days (A) and 11 days (B) after seeding. (C,D) The scaffold was seeded with 2000 cell/mm3 hBM-MSCs and stained with Ki-67 (red, actively proliferating cells), 4′,6-diamidino-2-phenylindole (DAPI) (blue, nuclei), and phalloidin (green, cytoplasm) 11 days after seeding. (E,F) The scaffolds were seeded with 2000 cell/mm3 hBM-MSCs, stimulated with osteogenic medium, and stained with anti-osteocalcin antibody (red, osteocalcin-producing cells and extracellular osteocalcin), 4′,6-diamidino-2-phenylindole (DAPI) (blue, nuclei), and phalloidin (green, cytoplasm) 21 days after seeding.